Takeaways From the NASP Annual Conference

November 21, 2024
All Posts

KODIAKOOLER recently capped off an exciting few days at the National Association of Specialty Pharmacy’s annual conference and expo. After speaking with partners at the booth and participating in key meetings centered on specialty pharmacy, several industry trends were evident. From specialty drug growth to immunology and oncologic biosimilars, it is an exciting time to be a stakeholder in the specialty pharmaceutical industry.

As a complete insulated packaging partner committed to understanding your needs, objectives; and strategies, we want to ensure that our research is shared and that you have the latest industry news. Here’s our summary of the key insights gained at NASP:

Specialty Pharmacy is Outpacing Traditional in Non-Retail Growth and Non-Discounted Spend.

“For non-retail, specialty growth outpaces traditional growth and now has ~72% share of non-discounted spend.” -IQVIA, 2024

According to IQVIA, over the past year, specialty drugs have continued to dominate the pharmaceutical industry. With 13.9% growth in 2024 for non-retail sales, the specialty pharmacy industry is becoming a staple in most healthcare systems. Combine this with the near 84% market share of mail-order non-discounted spend, and it becomes clear that patients consistently want convenient specialty pharmaceuticals. Growing demand in these areas has health systems wrestling with one question,

‘how do we effectively distribute our specialty drugs?’

With mail order and non-retail specialty pharmaceuticals leading the industry in growth and market share, finding secure ways to deliver drugs reliably is crucial. KODIAKOOLER exists for this very purpose. With effective and sustainable insulated packaging, KODIAKOOLER is positioned to deliver unique solutions to any goals a brand may have.

Immunology and Oncology

Similar to insights at the Asembia ASX24 summit, immunology and oncology are leading the specialty pharmaceutical industry in total sales and growth. However, there is a projected slowing of growth in these industries with biosimilars beginning to saturate the market. So what can drug manufacturers do to ensure they are not entering an oversaturated market? Specialize their biosimilars and find untapped molecules. In the report “Biosimilars in the United States, 2023-2027”, IQVIA highlights the effectiveness of being the first few biosimilars to a given market: “To date, being first or second to launch has generally been a significant advantage.”

Cold Chain Packaging in the Specialty Pharmacy Industry

Through the conversations KODIAKOOLER had with attendees, we began to understand the lack of quality alternatives in the cold chain packaging market. Many of the conversations centered around big, bulky, and overly complicated packaging. At KODIAKOOLER, we pride ourselves on providing simple and effective cold chain packaging solutions that keep the pharmacist and patient in mind. Check out our pre-qualified Kotton shippers and see how KODIAKOOLER changes the game by putting performance over thickness.

Your Complete Insulated Packaging Partner

KODIAKOOLER provides a comprehensive range of insulated packaging solutions to meet our customers’ diverse needs. From our classic, high-performance Kotton liners to our biodegradable foam coolers, we offer a variety of options to suit your specific requirements. Our team of experts is here to help you select the perfect packaging solution for your objectives, ensuring optimal temperature control and a seamless shipping experience.

Temperature control shouldn’t come at the expense of a healthy planet, and being eco-friendly shouldn’t come at the expense of performance. Our biodegradable foam coolers and Kotton liners are a testament to our belief in that philosophy. At KODIAKOOLER, we’re committed to the next generation of insulated packaging, offering you exceptional performance and investing in sustainability.